Skip to Main Content

Author Details

Jos?? Barber??n
Hospital Universitario HM Monteprincipe, HM Hospitales
1991
116
19
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36510684Antimicrobial resistance in Gram-negative bacilli in Spain: an experts' view.Rev Esp Quimioter2023
37465867Recommendations for the prevention of healthcare-associated infections in nursing homes.Rev Esp Quimioter2023
35041328Decalogue for the selection of oral antibiotics for lower respiratory tract infections.Rev Esp Quimioter2022
35822605Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences.Rev Esp Quimioter2022
35491287Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units.Arch Bronconeumol2022
35655660Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study.Lancet Reg Health Eur2022
36193985Cefiderocol. Summary and conclusions.Rev Esp Quimioter2022
35012962Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.Life Sci Alliance2022
33291864Community-acquired pneumonia: similarities and differences between European and American guidelines - A narrative review.Rev Esp Quimioter2021
35011967ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome.J Clin Med2021
34693705Recommendations for antibiotic selection for severe nosocomial infections.Rev Esp Quimioter2021
34598419Dalbavancin.Rev Esp Quimioter2021
34075384Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization.medRxiv2021
34319057[Safety in the selection of oral antibiotic treatment in community infections, beyond COVID-19].Rev Esp Quimioter2021
34008930Clinical characteristics and outcomes of 1,331 patients with COVID-19: HM Spanish Cohort.Rev Esp Quimioter2021
32766668[Development of a predictive model for hospital mortality and re-admission in a cohort of infected patients that require hospitalization].Rev Esp Quimioter2020
33246358Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ÿ-lactamase producing Enterobacterales in patients with diabetic foot infections requiring hospital admission.Rev Esp Quimioter2020
33070578Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings.Rev Esp Quimioter2020
30630306Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.Rev Esp Quimioter2019
31795630[Three keys to the appropriate choice of oral antibiotic treatment in the respiratory tract infections].Rev Esp Quimioter2019
31364339Possible clinical indications of ceftobiprole.Rev Esp Quimioter2019
31364334Introduction.Rev Esp Quimioter2019
29480677Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy.Rev Esp Quimioter2018
30284414[Integral approach to the acute exacerbation of chronic obstructive pulmonary disease].Rev Esp Quimioter2018
29569044Impact of a training program on adherence to recommendations for care of venous lines in internal medicine departments in Spain.Eur J Clin Microbiol Infect Dis2018
28056830Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp.BMC Infect Dis2017
28198169[Consensus document on pneumococcal vaccination in adults at risk by age and underlying clinical conditions. 2017 Update].Rev Esp Quimioter2017
28129820[Potential indications of dalbavancin in clinical practice].Enferm Infecc Microbiol Clin2017
29199418[Cefditoren: a reality for the treatment of community infections].Rev Esp Quimioter2017
29115367BAHNG score: predictive model for detection of subjects with the oropharynx colonized by uncommon microorganisms.Rev Esp Quimioter2017
28716670Nationwide study on peripheral-venous-catheter-associated-bloodstream infections in internal medicine departments.J Hosp Infect2017
275800092016 Expert consensus document on prevention, diagnosis and treatment of short-term peripheral venous catheter-related infections in adult.Rev Esp Quimioter2016
27608316[Invasive pulmonary aspergillosis in non-neutropenic patients].Rev Esp Quimioter2016
27174077How should we approach Aspergillus in lung secretions of patients with COPD?Rev Esp Quimioter2016
25614377Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients.Arch Bronconeumol2015
26033002[Isolated iliac aneurysm and positive FTA-Abs test].Rev Esp Quimioter2015
25904513[Tigecycline: 10 years of history and still in full force].Rev Esp Quimioter2015
25824558Nationwide study on the use of intravascular catheters in internal medicine departments.J Hosp Infect2015
24676248Guidelines for the management of community-acquired pneumonia in the elderly patient.Rev Esp Quimioter2014
25443031[Diabetic foot: what is the most appropriate therapeutic approach?].Enferm Infecc Microbiol Clin2014
25481431[Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].Rev Iberoam Micol2014
25536426[Ebola virus disease, an overview of the problem].Rev Esp Quimioter2014
25036264Recommendations for vaccination against pneumococcus in kidney patients in Spain.Nefrologia2014
24996840High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: a comparative study.Diagn Microbiol Infect Dis2014
24940892Report of 38 cases of tracheobronchitis in non-immunocompromised patients with dual isolation of Aspergillus in lower respiratory tract samples.Rev Esp Quimioter2014
24873864[Consensus guidelines for the management of community acquired pneumonia in the elderly patient].Rev Esp Geriatr Gerontol2014
24702976[Role of ceftaroline in skin and soft tissue infections].Enferm Infecc Microbiol Clin2014
23276610[Multidisciplinary guidelines for the management of community-acquired pneumonia].Med Clin (Barc)2013
24399355Treatment of invasive fungal infections in high-risk haematological patients: what have we learnt in the past 10 years?Rev Esp Quimioter2013
24080892[Consensus document on pneumococcal vaccination in adults with risk underlying clinical conditions].Rev Esp Quimioter2013
  • 1 - 50 of 116

Recommended Authors

Matthew W McCarthy
Weill Cornell Medical College, New York-Presbyterian Hospital
Career Start Year 2014
Number of shared co-authors 0
Monica V Mahoney
Department of Pharmacy, Beth Israel Deaconess Medical Center
Career Start Year 2013
Number of shared co-authors 0
Carlos Palos
Hospital Beatriz Angelo
Career Start Year 2012
Number of shared co-authors 0
Carla McWilliams
Cleveland Clinic Florida Weston
Career Start Year 2011
Number of shared co-authors 0
Enrico Maria Trecarichi
University "Magna Graecia"
Career Start Year 2006
Number of shared co-authors 0
Johanna Osorio
Hospital Universitario Hernando Moncaleano Perdomo
Career Start Year 2006
Number of shared co-authors 0
Anurag N Malani
Trinity Health St Joseph Mercy Hospital
Career Start Year 2005
Number of shared co-authors 0
Paschalis Vergidis
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Anders Ternhag
Karolinska Institutet
Career Start Year 2004
Number of shared co-authors 0
Parham Sendi
Institute for Infectious Diseases, University of Bern
Career Start Year 2004
Number of shared co-authors 1
Mercedes Nieto
Hospital Clinico San Carlos
Career Start Year 2003
Number of shared co-authors 3
Andre C Kalil
University of Nebraska School of Medicine
Career Start Year 2002
Number of shared co-authors 2
Susana Hernando
University Hospital Fundacion Alcorcon
Career Start Year 2001
Number of shared co-authors 1
Fernando Mart??nez-Sagasti
Hospital Clinico San Carlos
Career Start Year 2000
Number of shared co-authors 3
Davut Ozdemir
Hacettepe University Faculty of Medicine
Career Start Year 2000
Number of shared co-authors 0
Luigia Scudeller
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Career Start Year 1999
Number of shared co-authors 1
Steven I Aronin
Waterbury Hospital
Career Start Year 1998
Number of shared co-authors 0
Fernanda P Silveira
Federal University of Rio de Janeiro
Career Start Year 1998
Number of shared co-authors 1
Yolanda Gil
Hospital Universitario de Mostoles C/Dr. Luis Montes
Career Start Year 1995
Number of shared co-authors 0
Grant W Waterer
University of Western Australia, Royal Perth Hospital
Career Start Year 1995
Number of shared co-authors 2
Priya Sampathkumar
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 0
Shmuel Shoham
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1993
Number of shared co-authors 0
Vance G Fowler
Duke University School of Medicine
Career Start Year 1991
Number of shared co-authors 0
Thomas Gr??newald
Hospital Chemnitz
Career Start Year 1991
Number of shared co-authors 1
Andy I M Hoepelman
University Medical Center Utrecht
Career Start Year 1988
Number of shared co-authors 3
A M Joffe
University of Washington
Career Start Year 1988
Number of shared co-authors 0
Richard G Wunderink
Northwestern University Feinberg School of Medicine
Career Start Year 1984
Number of shared co-authors 2
Coleman Rotstein
University of Toronto, and University Health Network, Toronto General Hospital
Career Start Year 1982
Number of shared co-authors 0
Thomas J Marrie
Dalhousie University
Career Start Year 1977
Number of shared co-authors 0
Bruce S Ribner
Emory University School of Medicine
Career Start Year 1975
Number of shared co-authors 1

Collaborators

Alejandro Rodr??guez
Hospital Universitario de Tarragona Juan XXIII
Co-authored papers 8
Jes??s Fort??n
Hospital Universitario Ramon y Cajal
Co-authored papers 5
Jose F Varona
Hospital Universitario HM Monteprincipe, HM Hospitales
Co-authored papers 3
Javier G??mez
Hospital Universitario Marques de Valdecilla
Co-authored papers 2
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Co-authored papers 2
Noemi Cabello
Centro Sandoval and Hospital Universitario Clinico de San Carlos
Co-authored papers 2
Greg J Towers
University College London
Co-authored papers 2
Beatriz de Rivas
University of the Basque Country UPV/EHU
Co-authored papers 2
Pablo Avil??s
Departamento de Toxicologia y Farmacologia Preclinica
Co-authored papers 2
Rubin Lubomirov
Clinical Development
Co-authored papers 2
Kirsten Obernier (CM4AI)
University of California San Francisco
Co-authored papers 2
Nuria Izquierdo-Useros
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Co-authored papers 2
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Salvador Fudio
Clinical Development
Co-authored papers 2
Soner Yildiz
University of Geneva
Co-authored papers 2
Julio Ancochea
Instituto de Salud Carlos III, Hospital Universitario La Princesa
Co-authored papers 2
Sonia Zu??iga
Campus Universidad Autonoma de Madrid
Co-authored papers 2
Roger Paredes
Hospital Germans Trias i Pujol
Co-authored papers 2
Daniel Carnevali-Ruiz
Hospital Universitario Quironsalud Madrid
Co-authored papers 2
Antonio Nieto
Clinical R&D
Co-authored papers 2
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Co-authored papers 2
Luis Enjuanes
Campus Universidad Autonoma de Madrid
Co-authored papers 2
Roberto Vates
Hospital Universitario de Getafe
Co-authored papers 2
Lucy Thorne
University College London
Co-authored papers 2
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 2
Daniel Abad
Universidad Europea
Co-authored papers 2
Pedro Landete
Hospital Universitario de La Princesa
Co-authored papers 2
Maria J S L Pontes
Co-authored papers 2
Alfonso Monereo
Hospital Universitario de Getafe
Co-authored papers 2
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 2
Release 1.2